According to the recent report “Live Cell Encapsulation Market by Technique (Dripping (Simple, Electrostatic), Coaxial Airflow, Liquid Jet), Polymer (Alginate, Chitosan, Silica, Cellulose Sulfate), Application (Probiotics, Transplant, Drug Delivery, Research) – Forecast to 2024″, The global live cell encapsulation market is projected to reach USD 303 million by 2024 from USD 250 million in 2018, at a CAGR of 3.2%.
Browse in-depth TOC on“Live Cell Encapsulation Market”
34 – Tables
29 – Figures
136 – Pages
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=218019375
The major factors driving the growth of the live cell encapsulation market are the rising public awareness related to the clinical role of encapsulated cells in disease management, increasing public-private investments to support product development, and the rising adoption of novel drug delivery systems for disease treatment.
Drug Delivery Application:
Cell encapsulation is undertaken for the manufacturing of tablets, capsules, and parenteral dosage forms for effective drug delivery. The growth of this segment includes the increasing adoption of cell encapsulation for drug delivery is mainly due to its procedural benefits (such as improved efficacy, reduced toxicity, and improved patient compliance & convenience).
Alginate polymers segment estimated to be the fastest-growing polymer type segment during the forecast period
Based on polymer type, the live cell encapsulation market is segmented into alginate, HEMA-MMA (hydroxyethyl methacrylate-methyl methacrylate), chitosan, siliceous encapsulates, cellulose sulfate, PAN-PVC [poly (acrylonitrile vinyl chloride)], and other polymers. The alginate segment is expected to grow at the highest CAGR during the forecast period primarily due to the procedural benefits such as uniform cell structures and high mechanical stability.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=218019375
North America to dominate the live cell encapsulation market during the forecast period
The live cell encapsulation market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. North America is estimated to be the largest regional market for live cell encapsulation in 2019 majorly due to the increasing clinical data for the efficacy of the cell encapsulation technique and the rising adoption of cell encapsulation techniques among medical professionals.